AVITA Medical, Inc. (RCEL)
11.58
+0.63
(+5.75%)
USD |
NASDAQ |
Sep 24, 16:00
11.56
-0.02
(-0.17%)
After-Hours: 19:59
AVITA Medical Gross Profit (Annual) : 58.82M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 58.82M |
| December 31, 2024 | 55.16M |
| December 31, 2023 | 42.36M |
| December 31, 2022 | 28.38M |
| June 30, 2021 | 23.28M |
| June 30, 2020 | 11.29M |
| June 30, 2019 | 4.296M |
| June 30, 2018 | 0.5324M |
| June 30, 2017 | 0.509M |
| June 30, 2016 | 0.4369M |
| June 30, 2015 | 1.662M |
| June 30, 2014 | 1.847M |
| June 30, 2013 | 2.119M |
| June 30, 2012 | 1.948M |
| Date | Value |
|---|---|
| June 30, 2011 | 1.579M |
| June 30, 2010 | 1.14M |
| June 30, 2009 | 0.5515M |
| June 30, 2008 | 0.3028M |
| June 30, 2007 | -1.102M |
| June 30, 2006 | -1.198M |
| June 30, 2005 | -1.274M |
| June 30, 2004 | -1.290M |
| June 30, 2003 | -0.5656M |
| December 31, 2002 | 0.0011M |
| December 31, 2001 | -0.2877M |
| December 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| December 31, 1998 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 1.091B |
| Iovance Biotherapeutics, Inc. | 54.38M |
| Amgen, Inc. | 26.01B |
| Editas Medicine, Inc. | 35.24M |
| Arcus Biosciences, Inc. | 237.00M |